Neurocognitive impairment is an independent risk factor for death in HIV infection

被引:164
作者
Ellis, RJ
Deutsch, R
Heaton, RK
Marcotte, TD
McCutchan, JA
Nelson, JA
Abramson, I
Thal, LJ
Atkinson, JH
Wallace, MR
Grant, I
Kelly, M
Chandler, JL
Spector, SA
Jernigan, T
Masliah, E
Dupont, R
机构
[1] UNIV CALIF SAN DIEGO, DEPT PSYCHIAT, SAN DIEGO, CA 92103 USA
[2] UNIV CALIF SAN DIEGO, DEPT MED, SAN DIEGO, CA 92103 USA
[3] UNIV CALIF SAN DIEGO, DEPT MATH, SAN DIEGO, CA 92103 USA
[4] NAVAL HOSP SAN DIEGO, DEPT MED, SAN DIEGO, CA USA
[5] SAN DIEGO VET AFFAIRS MED CTR, SAN DIEGO, CA USA
关键词
D O I
10.1001/archneur.1997.00550160054016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine if mortality is increased in individuals with human immunodeficiency virus type 1 (HIV-1)-associated neurocognitive disorders less severe than frank dementia. Design: A prospective cohort study; median duration of follow-up was 2.4 years. Kaplan-Meier analysis and Cox proportional hazards models were used to compare survival times according to neurocognitive classification. Setting: University-based research unit. Participants: A volunteer sample of 414 individuals seropositive for HIV-1. Subjects were classified at their baseline evaluation as neuropsychologically (NP) normal or abnormal (impaired in greater than or equal to 2 NP test domains). A subgroup of NP abnormal subjects met operational criteria for HIV-associated minor cognitive motor disorder; the remaining subjects were designated NP impaired. Subjects with frank dementia were excluded. Main Outcome Measure: Mortality. Results: At the baseline evaluation, 256 (62%) of 414 subjects were designated normal; 109 (26%), NP impaired; and 49 (12%), minor cognitive motor disorder. One hundred six participants (26%) died during followup. Compared with the NP normal group, the unadjusted relative risk (RR) of death for all NP abnormal subjects (minor cognitive motor disorder and NP impaired) was significantly increased (RR, 1.7; 95% confidence interval [CI], 1.2-2.6; P<.005). After adjusting for concurrently measured predictors of survival (CD4 lymphocyte counts, Centers for Disease Control and Prevention HIV disease classification, hemoglobin concentration, and serum beta(2)-microglobulin) in proportional hazards models, mortality for all NP abnormal subjects remained elevated (RR, 1.8; 95% CI, 1.2-2.8; P<.01). The elevation in mortality risk for subjects with minor cognitive motor disorder was statistically significant (RR, 2.2; 95% CI, 1.2-3.8; P<.01); for NP impaired subjects it was marginally significant (RR, 1.6; 95% CI, 1.0-2.8; P=.06). Conclusions: The HIV-infected individuals with NP impairment had a higher risk of dying than those without impairment. This was particularly true for those meeting syndromic diagnostic criteria.
引用
收藏
页码:416 / 424
页数:9
相关论文
共 57 条
  • [1] [Anonymous], 1992, MMWR Recomm Rep, V41, P1
  • [2] Association AP, 1987, DIAGN STAT MAN MENT
  • [3] MULTIVARIATE MODELS FOR PREDICTING PROGRESSION TO AIDS AND SURVIVAL IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS
    BLATT, SP
    MCCARTHY, WF
    BUCKOKRASNICKA, B
    MELCHER, GP
    BOSWELL, RN
    DOLAN, MJ
    FREEMAN, TM
    RUSNAK, JM
    HENSLEY, RE
    WARD, WW
    BARNES, D
    HENDRIX, CW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) : 837 - 844
  • [4] INFLUENCE OF NEUROLOGIC MANIFESTATIONS OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON DISEASE PROGRESSION
    BOUFASSA, F
    BACHMEYER, C
    CARRE, N
    DEVEAU, C
    PERSOZ, A
    JADAND, C
    SERENI, D
    BUCQUET, D
    ROUZIOUX, C
    DELLAMONICA, P
    GALLAIS, H
    DELFRAISSY, JF
    LEFRERE, JJ
    CASSUTO, JP
    DUPONT, B
    VITTECOQ, D
    HERSON, S
    GASTAUT, JA
    VILDE, JL
    KATLAMA, C
    SOBEL, A
    DUVAL, J
    KAZATCHKINE, M
    LEBRAS, P
    EVEN, P
    GUILLEVIN, L
    MEYER, L
    DEVEAU, C
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) : 1190 - 1195
  • [5] ASSESSMENT OF AIDS-RELATED COGNITIVE CHANGES - RECOMMENDATIONS OF THE NIMH WORKSHOP ON NEUROPSYCHOLOGICAL ASSESSMENT APPROACHES
    BUTTERS, N
    GRANT, I
    HAXBY, J
    JUDD, LL
    MARTIN, A
    MCCLELLAND, J
    PEQUEGNAT, W
    SCHACTER, D
    STOVER, E
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1990, 12 (06) : 963 - 978
  • [6] TRENDS AND SURVIVAL FOR AIDS PATIENTS PRESENTING WITH INDICATIVE NEUROLOGIC DISEASES
    CASABONA, J
    SANCHEZ, E
    GRAUS, F
    ABOS, J
    SEGURA, A
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (01): : 51 - 55
  • [7] *CDCP, 1995, MMWR-MORBID MORTAL W, V44, P401
  • [8] Checko P J, 1994, Conn Med, V58, P661
  • [9] Chelune GJ., 1986, ADV CLIN NEUROPSYCHO
  • [10] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS PRESENT IN THE CEREBROSPINAL-FLUID OF A MAJORITY OF INFECTED INDIVIDUALS
    CHIODI, F
    KEYS, B
    ALBERT, J
    HAGBERG, L
    LUNDEBERG, J
    UHLEN, M
    FENYO, EM
    NORKRANS, G
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) : 1768 - 1771